Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected millions of people around the globe. The most common presentation of COVID-19 is fever and upper and lower respiratory tract infection. Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves. There is very scant literature on autoimmune myositis triggered by COVID-19 infection. We report a case of SARS-CoV-2 infection, who presented with progressive muscle weakness with rhabdomyolysis and necrotizing autoimmune myopathy on muscle biopsy. This case report imposes awareness of musculoskeletal autoimmune processes triggered by COVID-19 which requires clinical suspicion for early diagnosis and initiation of treatment.
Original language | English (US) |
---|---|
Article number | e239457 |
Journal | BMJ case reports |
Volume | 14 |
Issue number | 4 |
DOIs | |
State | Published - Apr 13 2021 |
Keywords
- infections
- muscle disease
- musculoskeletal and joint disorders
- neurology (drugs and medicines)
ASJC Scopus subject areas
- Medicine(all)